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Abstract 
Identification of ST elevation on the electrocardiogram (ECG) is the cornerstone of diagnosis of ST-
elevation myocardial infarction (STEMI). While lesion localisation can usually be achieved by regional ST-
elevation patterns on ECG, clinicians often neglect changes in the ST segment of lead aVR, possibly 
contributing to delayed recognition and poorer outcomes for these patients. This study compared the 
'door-to-balloon time' and peak troponins - as a surrogate marker of infarct size - for patients presenting 
with STEMI with ST-segment elevation in aVR compared with those patients without elevation in aVR. A 
total of 179 patients, including 17 patients presenting with ST-elevation in aVR, were included in this 
study. Patients presenting with elevation in aVR had significantly longer door-to-balloon times than those 
patients presenting with 'traditional' patterns of ST-elevation. There was, however, no significant 
difference in peak troponin as a marker of infarct size. While patients presenting with ST-elevation in lead 
aVR may have a delayed time to intervention, the present study does not suggest the use of aVR elevation 
as an indication for urgent angiography. 
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Figure 1. ST-elevation in aVR
(https://bjcardio.co.uk/wp-content/uploads/2018/01/Screen-Shot-
2018-01-17-at-13.34.22.png)
Identification of ST elevation on the electrocardiogram (ECG) is the cornerstone of diagnosis of ST-elevation myocardial 
infarction (STEMI). While lesion localisation can usually be achieved by regional ST-elevation patterns on ECG, clinicians 
often neglect changes in the ST segment of lead aVR, possibly contributing to delayed recognition and poorer outcomes for 
these patients.
This study compared the ‘door-to-balloon time’ and peak troponins – as a surrogate marker of infarct size – for patients 
presenting with STEMI with ST-segment elevation in aVR compared with those patients without elevation in aVR. A total of 
179 patients, including 17 patients presenting with ST-elevation in aVR, were included in this study. Patients presenting 
with elevation in aVR had significantly longer door-to-balloon times than those patients presenting with ‘traditional’ 
patterns of ST-elevation. There was, however, no significant difference in peak troponin as a marker of infarct size. While 
patients presenting with ST-elevation in lead aVR may have a delayed time to intervention, the present study does not 
suggest the use of aVR elevation as an indication for urgent angiography.
Introduction
The variety of electrocardiogram (ECG) changes that occur 
following acute myocardial infarction (AMI), occur in 
concordance with coronary circulation anatomy. ST-segment 
elevation in lead aVR can indicate an anterior wall AMI.
However, lead aVR is commonly neglected by clinicians, and 
as such, this may be a potential source of adverse patient 
outcomes.
The aim of this single-centre study is to investigate how 
proficiently AMIs presenting with aVR ST-elevation are 
recognised, using ‘door-to-balloon times’ as an outcome 
measure in patients having primary percutaneous coronary intervention (PCI) or those having elective PCI within 24 hours of acute 
coronary syndrome (ACS), with significant occlusion. The secondary objective was to determine whether poor recognition translates 
to larger infarction using a surrogate measure of peak troponin levels compared with patients meeting standard ST-elevation 
myocardial infarction (STEMI) criteria. A sample ECG demonstrating elevation in aVR is shown in figure 1.
Materials and methods
This was a retrospective cohort study performed at a single tertiary institution, using The Wollongong Hospital (TWH) catheterisation 
database. Ethics approval was granted by TWH and the University of Wollongong Human Research Ethics Committee. TWH 
catheterisation database was searched for non-ST-elevation myocardial infarction (NSTEMI) and STEMI patients over a two-year 
period ending December 2013. De-identified, coded data included: ECG and basic clinical and demographic data including age, 
gender, family history of cardiovascular disease, smoking status, hypercholesterolaemia, hypertension and diabetes mellitus. The 
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Table 1. Basic demographic and clinical variables in 
aVR ST-elevation myocardial infarction (STEMI) and 
other STEMI patients
time from onset of symptoms until presentation at triage, and door-to-balloon times were also recorded. Patients included in this 
study were those that had a primary PCI, or elective PCI within 24 hours post-ACS, with a significant occlusion. Occlusion was defined 
as a thrombolysis in myocardial infarction (TIMI) score of 0 or 1. Troponin and angiography results were interpreted by the treating 
cardiology consultant at the time of admission.
All ECGs were independently analysed by a trained investigator (JW) who was blinded to identity and other clinical variables. ST-
segment elevation was determined to be present if greater than 0.5 mm, in keeping with current ACS guidelines. Confounders that 
commonly mimic occlusion on ECG, including hyperkalaemia (>5.5 mEq/L), tachycardia (>130 bpm), pulmonary oedema with 
respiratory failure and diastolic blood pressure (DBP) >120 mmHg were excluded. Patients were also excluded if they had a 
pacemaker, were post-cardiac arrest or presenting with re-infarction within one week due to likely confounding ECG abnormalities 
or persistence of troponin elevation. Patients transferred from other wards or operating theatres were also excluded as this study 
aimed to specifically include those patients presenting from the community, not already in monitored medical care, where 
identification of ECG changes and symptoms at an earlier stage may have expedited transfer for angiography. Statistical analyses 
were performed using SPSS (version 21.0; SPSS, Inc., Chicago). Independent samples t-tests were used to compare continuous 
variables. Significance was set at p<0.05.
Results
During the data collection period, 1,429 patients underwent 
coronary angiography at TWH. Of these, 28 met exclusion 
criteria, 375 had missing data, 807 had either no lesion or 
TIMI flow ≥2 on elective PCI. Of the remaining 219 patients, 17 
met aVR ST-elevation criteria and 162 met STEMI criteria. 
Patient demographics for aVR ST-elevation and STEMI groups 
are presented in table 1.
When comparing patients with aVR elevation to patients 
without elevation in aVR, there was a significant trend 
towards longer door-to-balloon time (2,759 ± 286 vs.
172 ± 526, p<0.001). There was no statistically significant 
difference between the initial troponins (147 ± 314 vs.
245 ± 889, p=0.41), or peak 24-hour troponins (1,833 ± 373 vs.
3,526 ± 380, p=0.14) between these groups. In the 17 patients 
with ST-elevation in aVR, angiography revealed occlusion 
could be in any of the coronary arteries – including left 
anterior descending (LAD) (39%), right coronary artery (RCA) 
(22%), diagonal (6%), circumflex (28%) and the left main 









This was a single-centre retrospective cohort study with the 
aim of determining how well ACS presenting with aVR ST-
elevation is recognised, using ‘door-to-balloon times’ as an 
outcome measure. The secondary aim was to determine 
whether this translates to a larger infarction through a 
surrogate measure of peak troponin levels.
The mechanism of ST-elevation in aVR in ACS is not fully 
understood. In the present study, a wide variety of coronary 
arteries were occluded in patients with aVR ST-elevation. This 
ECG pattern has previously been attributed to LMCA 
occlusion. However, the present study illustrates that the 
pattern is not confined to an occlusion in this vessel, with only 
one of the 17 aVR AMI patients presenting with an LMCA 
occlusion.
This was a single-centre retrospective study, with a small 
number of aVR AMI patients, limiting the statistical power of 
this study. Unmeasured confounders, including angiography 
lab availability, communication, staffing and volume of 
emergency department presentations, may also influence the 
‘door-to-balloon time’ used here as a surrogate measure of 
recognition of STEMI with aVR ST-elevation. Although delay in 
door-to-balloon time was not associated with increased 
infarct size, troponin rise can be confounded by other factors 
such as renal failure. Although the correlation of troponin elevation and infarct size is established, additional measures that were 
not available in this study, but may be useful in further characterising this end point, include cardiac magnetic resonance imaging 
(MRI) for illustration of infarct size, as well as long-term outcomes of cardiac function.
In this study there was a significantly longer door-to-balloon time in the aVR ST-elevation group compared with the group of patients 
with STEMI indicated by elevation in other ECG leads. This did not, however, result in a significantly larger size of infarction, as shown 
by peak troponin levels. Despite a significant delay in the transfer of patients for angiography, this lack of recognition and/or 
prioritisation of ST-segment elevation in aVR has no significant impact on infarction size. Therefore, the present study does not 
support the inclusion of ST-segment elevation in aVR into the criteria for urgent angiography.
Key messages
• Patients presenting with ST-elevation in aVR may be under-recognised as cases of ST-elevation myocardial infarction (STEMI) 
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• This delayed time to intervention does not correlate with higher peak troponins as a surrogate measure of infarct size, and, 
therefore, does not suggest that aVR ST-elevation should be used as an indication for urgent angiography
• While aVR elevation has been traditionally associated with left main coronary artery (LMCA) stenosis or occlusion, the present 
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